EUVIMED · CrossrefZeitschrift
International Journal of Urology
ISSN 0919-8172 · Wiley
Neueste Artikel
Prolonged and Nocturnal Hypoglycemia Following Resection of Pheochromocytoma and Paraganglioma: A Prospective Study Using Intermittent‐Scanning Continuous Glucose Monitoring
A Trial‐Level Benefit–Toxicity Mapping Framework for Adjuvant Therapy in Renal Cell Carcinoma: A Focused Review
External Validation of Existing Nomograms on Indian Prostate Biopsy Data
Editorial Comment to Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy
Magnetic Resonance Imaging Findings and Prostate‐Specific Antigen Density‐Based Risk Stratification for Deferring a Separate Preoperative Biopsy in Candidates for Holmium Laser Enucleation of the Prostate
Five‐Year Clinical Outcomes Following Nephrectomy for Renal Cell Carcinoma: Evidence From a Nationwide Japanese Surgical Registry
Sensitivity of mHSPC Overall Survival Network Estimates to the Historical Docetaxel Bridge
Beyond Association: Clarifying the Biological and Clinical Value of Urinary EphA2 in Bladder Cancer
Beyond Surgical Technique: Prostate Cancer Assessment and Treatment Sequencing Before HoLEP
Editorial Comment to Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle‐Invasive Bladder Cancer: A Copula‐Based Secondary Analysis
Urethroplasty for Anterior Urethral Stricture in Men With Non‐Muscle‐Invasive Bladder Cancer: Feasibility and Durability of a Pragmatic Recurrence‐Free Interval‐Oriented Strategy
Impact of Prior Holmium Laser Enucleation of the Prostate on Outcomes After Robot‐Assisted Radical Prostatectomy
Urinary Extracellular Vesicle–Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer
Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle‐Invasive Bladder Cancer: A Copula‐Based Secondary Analysis
Development and Validation of the JIKEI ‐ YAYOI Score for Predicting Castration Resistance in Metastatic Castration‐Sensitive Prostate Cancer Treated With ARSI ‐Based Doublet Therapy
Survival Benefit of ARSI Therapy in Japanese mCSPC : A Systematic Review and Meta‐Analysis
Consensus‐Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic Oncology
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects
Editorial Comment to Real‐World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study
Clinical Implications of Glomerulation After Cystoscopic Hydrodistention in Patients With Interstitial Cystitis and Bladder Pain Syndrome
Myosteatosis Predicts Poor Prognosis in Patients With Castration‐Resistant Prostate Cancer Treated With Enzalutamide
Real‐World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study
Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low‐ and Intermediate‐Risk Localized Prostate Cancer
Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR ‐ TKIs in Real‐World Patients With Advanced Renal Cell Carcinoma
Technique Selection for Robot‐Assisted Radical Prostatectomy: A Multi‐Institutional Survey in Japan
Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real‐World Multicenter Retrospective Study
TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma
Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: YUSHIMA Study
Effectiveness of the Ureteral Illuminating Catheter in Securing Adhesive Ureters in Robot‐Assisted Ureteral Reconstruction
Geriatric Nutritional Risk Index Predicts Postoperative Complications in Elderly Patients Undergoing Robot‐Assisted Radical Cystectomy
Jahrgänge
2026 · 3052025 · 3562024 · 2842023 · 2502022 · 3482021 · 3112020 · 2742019 · 3132018 · 2572017 · 2232016 · 2772015 · 3232014 · 4162013 · 2852012 · 2542011 · 2212010 · 2332009 · 2232008 · 2512007 · 2912006 · 3872005 · 2402004 · 2532003 · 1762002 · 1632001 · 1822000 · 1201999 · 1261998 · 1461997 · 1411996 · 1731995 · 971994 · 66
EUVIMED